1. Resistance Training for Glycemic Control, Muscular Strength, and Lean Body Mass in Old Type 2 Diabetic Patients: A Meta-Analysis

   • JungHoon Lee
   • DoHoun Kim
   • ChangKeun Kim

   Review Open access 05 April 2017 Pages: 459 - 473

   

2. A Practical Review of C-Peptide Testing in Diabetes

   • Emma Leighton
   • Christopher AR Sainsbury
   • Gregory C. Jones

   Review Open access 08 May 2017 Pages: 475 - 487

   

3. A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach

   • Sverre Christian Christiansen
   • Anders Lyngvi Fougner
   • Sven Magnus Carlsen

   Review Open access 13 May 2017 Pages: 489 - 506

   

4. Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines

   • Felice Strollo
   • Sandro Gentile

   Commentary Open access 26 April 2017 Pages: 507 - 511

5. Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK

   • Gabriela Vega-Hernandez
   • Radek Wojcik
   • Max Schlueter

   Original Research Open access 27 March 2017 Pages: 513 - 530

   

6. IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting

   • Barnaby Hunt
   • Michelle Mocarski
   • Jakob Langer

   Original Research Open access 27 March 2017 Pages: 531 - 544

   

7. Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus^® Insulin Glargine

   • Liza L. Ilag
   • Timothy M. Costigan
   • Melvin J. Prince

   Original Research Open access 30 March 2017 Pages: 545 - 554

   

8. Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

   • Zhou Zhou
   • Paresh Chaudhari
   • Raafat Seifeldin

   Original Research Open access 30 March 2017 Pages: 555 - 571

   

9. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

   • Thomas Haak
   • Hélène Hanaire
   • Gerry Rayman

   Original Research Open access 11 April 2017 Pages: 573 - 586

   

10. Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

    • Mikaela Sjöstrand
    • Cheryl Wei
    • Boaz Hirshberg

    Original Research Open access 21 April 2017 Pages: 587 - 599

    

11. The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA_1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study

    • So Ra Kim
    • Yong-ho Lee
    • Byung-Wan Lee

    Original Research Open access 22 March 2017 Pages: 601 - 609

    

12. Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

    • Yujing Jin
    • Xiaowei Sun
    • Tiehong Zhu

    Original Research Open access 27 March 2017 Pages: 611 - 621

    

13. Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

    • Yujing Jin
    • Xiaowei Sun
    • Tiehong Zhu

    Erratum Open access 11 April 2017 Pages: 623 - 624

14. The Impact of Frequency and Tone of Parent–Youth Communication on Type 1 Diabetes Management

    • Mark D. DeBoer
    • Rupa Valdez
    • Stephen Patek

    Original Research Open access 12 April 2017 Pages: 625 - 636

15. Indian Injection Technique Study: Population Characteristics and Injection Practices

    • Sanjay Kalra
    • Ambrish Mithal
    • Kenneth W. Strauss

    Original Research Open access 13 March 2017 Pages: 637 - 657

    

16. Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional

    • Sanjay Kalra
    • Ambrish Mithal
    • Kenneth W. Strauss

    Original Research Open access 13 March 2017 Pages: 659 - 672

    

17. Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program

    • Kamlesh Khunti
    • Viswanathan Mohan
    • Bipin Sethi

    Brief Report Open access 22 March 2017 Pages: 673 - 682

    

18. Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients

    • Jürgen Harreiter
    • Lana Kosi-Trebotic
    • Michael R. Krebs

    Brief Report Open access 29 March 2017 Pages: 683 - 692

    

19. The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

    • Tomoya Mita
    • Naoto Katakami
    • SPIKE Trial Site Investigators

    Brief Report Open access 17 May 2017 Pages: 693 - 704